Research from the Harold Hamm Oklahoma Diabetes Center indicates that Type 1 diabetes will respond to insulin and Vitamin C. When used together, they can prevent damage to blood vessels. They are hoping this will extend to Type 2 diabetes as well.
Michael Ihnat, Ph.D, is the principal investigator. He is a pharmacologist at OU College of Medicine Department of Cell Biology.
"The goal of the work being done by Ihnat and British scientists from the University of Warwick led by Dr. Antonio Ceriello is to find a way to stop the damage to blood vessels that is caused by diabetes. The damage, known as endothelial dysfunction, is associated with most forms of cardiovascular disease such as hypertension, coronary artery disease, chronic heart failure, peripheral artery disease, diabetes and chronic renal failure."
Patients with Type 1 diabetes could be spared the damage of heart disease, decreased circulation possibly leading to amputation and kidney disease. Diabetic retinopathy which often results in blindness could also be avoided through the combination of insulin and Vitamin C.